Equity Medical

Bowling Green, Kentucky 42104

2 studies enrolling now · 10 studies all time

What they study most

Atopic Dermatitis, Atoptic Dermatitis, Chronic Cutaneous Lupus Erythematosus, Chronic Spontaneous Urticaria, Hidradenitis Suppurativa (HS), Moderate Psoriasis, Nodular Basal Cell Carcinoma, Plaque Psoriasis, Prurigo Nodularis, Psoriasis, Psoriasis (PsO), Severe Psoriasis

Studies at this site

• Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa — Recruiting now
• Study of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC) — Recruiting now
• A Study of Barzolvolimab in Patients With Prurigo Nodularis — Running, not enrolling
• A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus — Running, not enrolling
• A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis — Running, not enrolling
• Phase 2b Study of EVO756 in Adults With Atopic Dermatitis — Running, not enrolling
• Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis — Running, not enrolling
• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) — Running, not enrolling
• A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Completed
• A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream — Completed